Last10K.com

Collplant Biotechnologies Ltd (CLGN) SEC Filing 20-F Annual Report for the fiscal year ending Friday, December 31, 2021

SEC Filings

CLGN Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

CLGN Annual Reports

  • 20-F Annual Report March 2022
    • 20-F Annual Report April 2019
    20-F Annual Report March 2018

CLGN Corporate News

Collplant Holdings Ltd.

HISTORY TOOLS
CIK: 1631487 Ticker: CLGN

View differences made from one year to another to evaluate Collplant Holdings Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Collplant Holdings Ltd..

Continue

Assess how Collplant Holdings Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Collplant Holdings Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operation
Consolidated Statements Of Shareholders??? Equity
Consolidated Statements Of Shareholders??? Equity (Parentheticals)
Accounting Policies, By Policy (Policies)
Commitments
Commitments (Details)
Development , Exclusivity And Option Products Agreements
Development , Exclusivity And Option Products Agreements (Details)
Fair Value Measurements
Fair Value Measurements (Details)
Fair Value Measurements (Details) - Schedule Of Assumptions Used For The Models
Fair Value Measurements (Details) - Schedule Of Level 3 Anti-Dilution Instrument
Fair Value Measurements (Tables)
General
Income Tax
Income Tax (Details)
Income Tax (Details) - Schedule Of Deferred Income Taxes
Income Tax (Details) - Schedule Of Valuation Allowance
Income Tax (Tables)
Inventories
Inventories (Details)
Inventories (Details) - Schedule Of Inventories
Inventories (Tables)
Operating Leases
Operating Leases (Details)
Operating Leases (Details) - Schedule Of Maturities Of Lease Liabilities
Operating Leases (Details) - Schedule Of Supplemental Balance Sheet Information Related To Leases
Operating Leases (Details) - Schedule Of Supplemental Cash Flow Information Related To Leases
Operating Leases (Tables)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Details) - Schedule Of Property And Equipment
Property And Equipment (Tables)
Share Capital
Share Capital (Details)
Share Capital (Details) - Schedule Of Changes In Number Of Options Granted
Share Capital (Details) - Schedule Of Changes In Number Of Options Granted
Share Capital (Details) - Schedule Of Fair Value Of Options Granted To Employees On The Date Of Grant Was Computed Using The Black-Scholes Model
Share Capital (Details) - Schedule Of Fair Value Of Options Granted To Non-Employees
Share Capital (Details) - Schedule Of Outstanding And Exercisable Options
Share Capital (Details) - Schedule Of Share-Based Compensation
Share Capital (Details) - Schedule Of Shares Issued Granted Options
Share Capital (Tables)
Significant Accounting Policies
Significant Accounting Policies (Details)
Significant Accounting Policies (Details) - Schedule Of Estimated Useful Lives Property And Equipment
Significant Accounting Policies (Tables)
Subsequent Events
Subsequent Events (Details)
Supplementary Financial Statement Information
Supplementary Financial Statement Information (Details)
Supplementary Financial Statement Information (Details) - Schedule Of Balance Sheet
Supplementary Financial Statement Information (Details) - Schedule Of Changes In Deferred Revenues Relating To Goods
Supplementary Financial Statement Information (Details) - Schedule Of Disaggregated Revenues Text Block
Supplementary Financial Statement Information (Details) - Schedule Of Financial Income (Expenses) ,Net
Supplementary Financial Statement Information (Details) - Schedule Of Revenue By Major Customers
Supplementary Financial Statement Information (Details) - Schedule Of Revenues By Geographical Area
Supplementary Financial Statement Information (Tables)
Ticker: CLGN
CIK: 1631487
Form Type: 20-F Annual Report
Accession Number: 0001213900-22-014666
Submitted to the SEC: Thu Mar 24 2022 9:21:57 AM EST
Accepted by the SEC: Thu Mar 24 2022
Period: Friday, December 31, 2021
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/clgn/0001213900-22-014666.htm